Shengzhi Liu

818 total citations
42 papers, 621 citations indexed

About

Shengzhi Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shengzhi Liu has authored 42 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Shengzhi Liu's work include Bone health and treatments (10 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Mass Spectrometry Techniques and Applications (5 papers). Shengzhi Liu is often cited by papers focused on Bone health and treatments (10 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and Mass Spectrometry Techniques and Applications (5 papers). Shengzhi Liu collaborates with scholars based in China, United States and Japan. Shengzhi Liu's co-authors include Hiroki Yokota, Bai‐Yan Li, Andy Chen, Amanda P. Siegel, Yao Fan, Mangilal Agarwal, Harikrishna Nakshatri, Akihiro Sudo, Kazumasa Minami and Di Wu and has published in prestigious journals such as Nature Communications, The Science of The Total Environment and Cancer Research.

In The Last Decade

Shengzhi Liu

39 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengzhi Liu China 17 326 252 121 74 65 42 621
Antonella Chiechi United States 17 369 1.1× 203 0.8× 88 0.7× 87 1.2× 152 2.3× 22 752
Stephanie T. Murphy United States 14 251 0.8× 107 0.4× 120 1.0× 102 1.4× 89 1.4× 22 729
Shye-Jye Tang Taiwan 16 460 1.4× 210 0.8× 55 0.5× 72 1.0× 64 1.0× 23 821
Aaron E. Robinson United States 13 308 0.9× 73 0.3× 46 0.4× 160 2.2× 151 2.3× 35 833
S-H Chang South Korea 7 315 1.0× 148 0.6× 143 1.2× 144 1.9× 81 1.2× 8 637
Ola Hadadeh Lebanon 12 342 1.0× 181 0.7× 72 0.6× 182 2.5× 94 1.4× 16 676
Chenghua Luo China 15 283 0.9× 118 0.5× 30 0.2× 84 1.1× 96 1.5× 59 749
Samir Hanash United States 9 565 1.7× 100 0.4× 41 0.3× 69 0.9× 57 0.9× 9 807
Valgarður Sigurðsson Sweden 12 279 0.9× 181 0.7× 48 0.4× 102 1.4× 31 0.5× 22 540
Yiting Jin China 15 438 1.3× 132 0.5× 93 0.8× 209 2.8× 62 1.0× 34 761

Countries citing papers authored by Shengzhi Liu

Since Specialization
Citations

This map shows the geographic impact of Shengzhi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengzhi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengzhi Liu more than expected).

Fields of papers citing papers by Shengzhi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengzhi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengzhi Liu. The network helps show where Shengzhi Liu may publish in the future.

Co-authorship network of co-authors of Shengzhi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengzhi Liu. A scholar is included among the top collaborators of Shengzhi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengzhi Liu. Shengzhi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shengzhi, Jin Cai, Xiaoyu Qian, et al.. (2025). TPX2 lactylation is required for the cell cycle regulation and hepatocellular carcinoma progression. Life Science Alliance. 8(6). e202402978–e202402978. 3 indexed citations
3.
Yang, Wenyan, et al.. (2025). Morusin Suppresses Pancreatic Cancer Cell Proliferation and Migrationby Targeting SLC6A12 to Inhibit NF-κB and β-catenin SignalingPathways. Recent Patents on Anti-Cancer Drug Discovery. 21. 1 indexed citations
4.
Zhang, Yi, Mingjie Wang, Ling Ye, et al.. (2024). HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression. Nature Communications. 15(1). 1314–1314. 24 indexed citations
6.
Siegel, Amanda P., Shengzhi Liu, Sunil S. Tholpady, et al.. (2023). Canine-Inspired Chemometric Analysis of Volatile Organic Compounds in Urine Headspace to Distinguish Prostate Cancer in Mice and Men. Cancers. 15(4). 1352–1352. 10 indexed citations
7.
Wang, Luqi, Shengzhi Liu, Maitri Kalra, et al.. (2022). Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time. Molecules. 27(13). 4277–4277. 5 indexed citations
8.
Li, Kexin, Shengzhi Liu, Feng Yan, et al.. (2022). Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs. Theranostics. 12(7). 3084–3103. 18 indexed citations
9.
Liu, Shengzhi, Di Wu, Xun Sun, et al.. (2021). Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone. Bone Research. 9(1). 32–32. 32 indexed citations
10.
Pan, Weiwei, et al.. (2021). Study on Reliability Improvement of Main Steam Isolation Valve Control in Nuclear Power Plants. Journal of Physics Conference Series. 2005(1). 12215–12215. 1 indexed citations
11.
Fan, Yao, Tomohiko Sano, Xinyu Zhao, et al.. (2021). Mechanical tibial loading remotely suppresses brain tumors by dopamine-mediated downregulation of CCN4. Bone Research. 9(1). 26–26. 7 indexed citations
12.
Liu, Shengzhi, Xun Sun, Kexin Li, et al.. (2021). Generation of the tumor-suppressive secretome from tumor cells. Theranostics. 11(17). 8517–8534. 27 indexed citations
13.
Fan, Yao, Andy Chen, Xinyu Zhao, et al.. (2020). Skeletal loading regulates breast cancer-associated osteolysis in a loading intensity-dependent fashion. Bone Research. 8(1). 9–9. 49 indexed citations
14.
Chen, Andy, Yue Wang, Yao Fan, et al.. (2019). Vinculin Force Sensor Detects Tumor-Osteocyte Interactions. Scientific Reports. 9(1). 5615–5615. 26 indexed citations
15.
Wang, Luqi, Yue Wang, Andy Chen, et al.. (2018). Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling. PMC. 4 indexed citations
16.
Liu, Shengzhi, Andy Chen, Bai‐Yan Li, et al.. (2018). Finite Element Analysis of the Mouse Distal Femur with Tumor Burden in Response to Knee Loading.. PubMed. 5(1). 863–871. 2 indexed citations
17.
Chen, Andy, Luqi Wang, Shengzhi Liu, et al.. (2018). Attraction and Compaction of Migratory Breast Cancer Cells by Bone Matrix Proteins through Tumor-Osteocyte Interactions. Scientific Reports. 8(1). 5420–5420. 21 indexed citations
18.
Liu, Shengzhi, Andy Chen, Bai‐Yan Li, et al.. (2018). Finite Element Analysis of the Mouse Distal Femur with TumorBurden in Response to Knee Loading. International Journal of Orthopaedics. 5(1). 863–871. 1 indexed citations
19.
Minami, Kazumasa, Shengzhi Liu, Liu Yang, et al.. (2017). Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis. Scientific Reports. 7(1). 45686–45686. 40 indexed citations
20.
Liu, Shengzhi, Yang Liu, Bai‐Yan Li, et al.. (2016). Salubrinal improves mechanical properties of the femur in osteogenesis imperfecta mice. Journal of Pharmacological Sciences. 132(2). 154–161. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026